Relationships of high‑sensitive C‑reactive protein and P‑wave dispersion in lone atrial fibrillation

Chinese Medical Journal

Volumn 128, Issue 11, 2015, Pages 1450-1454

  Zheng, Li Hui ^a   Yao, Yan ^a   Wu, Ling Min ^a   Zhang, Kui Jun ^a   Zhang, Shu ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Atrial fibrillation; High sensitive C reactive protein; Inflammation; P wave dispersion

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; PROPAFENONE; WARFARIN;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERLIPIDEMIA; LEFT ATRIAL DIAMETER; LEFT VENTRICULAR END DIASTOLIC DIAMETER; MAJOR CLINICAL STUDY; MALE; P WAVE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; TURBIDIMETRY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84930173982     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.157649     Document Type: Article

References (23)

1. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998;135:733-8.
2. Gonna H, Gallagher MM, Guo XH, Yap YG, Hnatkova K, Camm AJ. P‑wave abnormality predicts recurrence of atrial fibrillation after electrical cardioversion: A prospective study. Ann Noninvasive Electrocardiol 2014;19:57-62.
3. Tuluce K, Ozerkan F, Yakar Tuluce S, Yavuzgil O, Gurgun C, Bilgin M, et al. Relationships between p wave dispersion, atrial electromechanical delay, left atrial remodeling, and NT‑proBNP levels, in patients with hypertrophic cardiomyopathy. Cardiol J 2015;22:94-100.
4. Guray U, Guray Y, Mecit B, Yilmaz MB, Sasmaz H, Korkmaz S. Maximum p wave duration and p wave dispersion in adult patients with secundum atrial septal defect: The impact of surgical repair. Ann Noninvasive Electrocardiol 2004;9:136-41.
5. Guntekin U, Gunes Y, Tuncer M, Gunes A, Sahin M, Simsek H. Long‑term follow‑up of P‑wave duration and dispersion in patients with mitral stenosis. Pacing Clin Electrophysiol 2008;31:1620-4.
6. Akdemir R, Ozhan H, Gunduz H, Tamer A, Yazici M, Erbilen E, et al. Effect of reperfusion on P‑wave duration and P‑wave dispersion in acute myocardial infarction: Primary angioplasty versus thrombolytic therapy. Ann Noninvasive Electrocardiol 2005;10:35-40.
7. Hashemi Jazi M, Amirpour A, Zavvar R, Behjati M, Gharipour M. Predictive value of P‑wave duration and dispersion in post coronary artery bypass surgery atrial fibrillation. ARYA Atheroscler 2012;8:59-62.
8. Guntekin U, Gunes Y, Simsek H, Tuncer M, Arslan S. P wave duration and dispersion in patients with hyperthyroidism and the short‑term effects of antithyroid treatment. Indian Pacing Electrophysiol J 2009;9:251-9.
9. Bhatt SP, Nanda S, Kintzer JS. Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease. Respir Med 2012;106:1134-8.
10. Aviles RJ, Martin DO, Apperson‑Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-10.
11. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves C‑reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96:3542-8.
12. Barassi A, Pezzilli R, Morselli‑Labate AM, Lombardi F, Belletti S, Dogliotti G et al. Serum amyloid A and C‑reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function. Can J Cardiol 2012;28:537-41.
13. Lin YJ, Tsao HM, Chang SL, Lo LW, Tuan TC, Hu YF, et al. Prognostic implications of the high‑sensitive C‑reactive protein in the catheter ablation of atrial fibrillation. Am J Cardiol 2010;105:495-501.
14. Conway DS, Buggins P, Hughes E, Lip GY. Relation of interleukin‑6, C‑reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation. Am J Cardiol 2004;93:1368-73, A6.
15. Tsioufis C, Syrseloudis D, Hatziyianni A, Tzamou V, Andrikou I, Tolis P, et al. Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects. Am J Hypertens 2010;23:202-7.
16. Tsioufis C, Syrseloudis D, Dimitriadis K, Thomopoulos C, Tsiachris D, Pavlidis P, et al. Disturbed circadian blood pressure rhythm and C‑reactive protein in essential hypertension. J Hum Hypertens 2008;22:501-8.
17. Emiroglu MY, Bulut M, Sahin M, Acar G, Akcakoyun M, Kargin R, et al. Assessment of atrial conduction time in patients with essential hypertension. J Electrocardiol 2011;44:251-6.
18. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-4.
19. Kumagai K, Nakashima H, Saku K. The HMG‑CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 2004;62:105-11.
20. Sata N, Hamada N, Horinouchi T, Amitani S, Yamashita T, Moriyama Y, et al. C‑reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? Jpn Heart J 2004;45:441-5.
21. Wallentin L, Hijazi Z, Andersson U, Alexander JH, De Caterina R, Hanna M, et al. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation 2014;130:1847-58.
22. Harada M, Van Wagoner DR, Nattel S. Role of inflammation in atrial fibrillation pathophysiology and management. Circ J 2015;79:495-502.
23. Gabay C, Kushner I. Acute‑phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.